Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,735 | 80,743 | 73,441 | 76,888 | 70,175 |
| Marketable Securities | 43,644 | N/A | N/A | N/A | N/A |
| Receivables | 39,913 | 42,610 | 47,663 | 62,467 | 41,608 |
| Inventories | 39,080 | 38,602 | 37,686 | 42,710 | 18,817 |
| TOTAL | $177,852 | $172,474 | $171,062 | $184,960 | $133,549 |
| Non-Current Assets | |||||
| PPE Net | 664 | 704 | 770 | 804 | 877 |
| Intangibles | 99,030 | 105,701 | 111,332 | 190,269 | 185,428 |
| Other Non-Current Assets | 1,897 | 3,086 | 3,255 | 3,995 | 85,325 |
| TOTAL | $101,591 | $109,491 | $115,357 | $195,068 | $271,630 |
| Total Assets | $279,443 | $281,965 | $286,419 | $380,028 | $405,179 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,271 | 15,650 | 13,439 | 19,004 | 11,182 |
| Accrued Expenses | 73,548 | 73,271 | 76,350 | 81,489 | 53,140 |
| Other current liabilities | 3,365 | 3,523 | 3,654 | 13,796 | 15,156 |
| TOTAL | $92,184 | $92,444 | $93,443 | $114,289 | $79,478 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,729 | 38,621 | 38,514 | 38,866 | 38,251 |
| Other Non-Current Liabilities | 16,377 | 16,406 | 16,459 | 34,000 | 33,179 |
| TOTAL | $55,106 | $55,027 | $54,973 | $72,866 | $71,430 |
| Total Liabilities | $147,290 | $147,471 | $148,416 | $187,155 | $150,908 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,336 | 95,125 | 94,996 | 94,669 | 56,517 |
| Common Shares | 9 | 9 | 9 | 9 | 5 |
| Retained earnings | -659,727 | -656,053 | -651,543 | -594,159 | -314,615 |
| TOTAL | $132,153 | $134,494 | $138,003 | $192,873 | $254,271 |
| Total Liabilities And Equity | $279,443 | $281,965 | $286,419 | $380,028 | $405,179 |